about
Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsSystematic review and meta-analysis of respiratory viral coinfections in childrenThe impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales, Australia.Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza.Evidence of the circulation of pandemic influenza (H1N1) 2009 with D222D/G/N/S hemagglutinin polymorphisms during the first wave of the 2009 influenza pandemic.The impact of bacterial and viral co-infection in severe influenzaViral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virusClinical and radiological predictors of outcome for Murray Valley encephalitis.Optimization is required when using linked hospital and laboratory data to investigate respiratory infections.Influenza outbreak during Sydney World Youth Day 2008: the utility of laboratory testing and case definitions on mass gathering outbreak containment.Using record linkage to validate notification and laboratory data for a more accurate assessment of notifiable infectious diseases.Modelling the seasonal epidemics of respiratory syncytial virus in young childrenUse of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children.Influenza outbreaks during World Youth Day 2008 mass gathering.Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infectionA prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant womenStreptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era.Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer.Antifungal therapy in children with invasive fungal infections: a systematic review.Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review.Influenza C infections in Western Australia and Victoria from 2008 to 2014.An observational study of febrile seizures: the importance of viral infection and immunization.Skull-base osteomyelitis: fungal vs. bacterial infection.Antifungal azoles: old and new.Pneumonia and lung infections due to emerging and unusual fungal pathogens.Bacillus cereus bacteremia and multiple brain abscesses during acute lymphoblastic leukemia induction therapy.Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.Predictors of Outcome in Pediatric Osteomyelitis: Five Years Experience in a Single Tertiary Center.Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.Influenza-Associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013-2015.Using record linkage to examine testing patterns for respiratory viruses among children born in Western Australia.Changing epidemiology of candidaemia in Australia.Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.Influenza hospitalizations in Australian children.A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand.Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore.
P50
Q24239978-22A802A9-0945-4304-986D-59E7B1DC0864Q26766050-E841F0AA-C71E-4F54-B8F7-DF92FFF86D97Q30363019-A98FC597-048F-4667-9E65-A97E6C0E5B7FQ30363739-63D26959-444F-4C46-97E2-0FDEE6F5C0B5Q30387994-B5410D50-B46C-4FC6-8CA3-045DE754FAD6Q30389366-F0B79687-FDB3-4CF9-B765-14C558E704D7Q30407215-3B90EA26-8F03-4E33-A43A-8FF0824FB80CQ30415172-2C56A07B-11D9-4ABD-8BD9-0095F7FC3E6CQ30427350-C5033A87-337C-4EB0-92DF-1299E58D38E3Q30584945-8FC4946F-9B0B-450A-8A00-2A864485EF43Q30989501-1CFD446C-E5C8-457C-8D1A-108248C8EE8EQ33499697-5AE0B094-A14D-4205-A00F-931F6E0106E7Q33808411-690566FE-69EF-4B7E-9040-F784B613EF4EQ33812186-F5741F53-E88D-4DD8-8E6A-5BF0C8F379B2Q34072955-666029DB-ADCD-43D7-9794-A78F5A9E4602Q34194046-542E37BF-779A-489A-9EB9-9787C10584BAQ35066568-BB43B223-F186-49D3-8190-B43867D71438Q35232946-157E8267-AD99-4D6D-A7D3-23AE63661977Q35828587-CFF78885-66D1-402F-8BCC-2B3F1A851D9AQ36528351-39A60225-1D6A-4A8B-A582-0C9351F9E22DQ36778360-9F571BA7-E7E3-4E4F-B390-1EB35F020CC3Q36834350-63802D5D-6837-4E03-BF45-FF06B95F1EB8Q37331072-8C7D51F2-4D0C-4CB7-A372-AC210BE57A55Q37470267-EABC730C-65C7-4501-9DD1-76E01D868E41Q37729271-5A011197-7318-40A4-A204-A76B25CD8647Q37876619-70E4CDAF-3BEA-4E32-A286-D2D6234EF0D9Q37968190-7E7C26E5-F487-48FC-BC14-87B43001A663Q38101789-836DC68C-F74F-47E4-91ED-946A70E45203Q38284447-AD50FB95-3079-4A88-9F74-88B3635B7D1BQ38284463-D4F6ACAC-5253-492C-8769-556BCC3B898DQ38669926-FD60C611-4E6F-480E-8CF2-50DA75F93849Q38684316-23B8911C-5698-4937-B9DD-34B487380FD1Q38706932-4F3B9954-ED9A-4CDE-AA37-211C9D7E2545Q38751857-3A68EA18-018F-44A1-87AD-F22DDDA69BC2Q38863487-920218AE-0138-43CE-B2DB-B9BB3B097C29Q38870252-7106CFAD-FB6A-41B9-A13D-9DF1E3242E5DQ38978442-DFDA0D33-AA8D-47B5-8BBE-1467EB4A05A8Q39013344-B819CF48-B806-4771-9F96-8A89EA67BDB2Q39093634-888F3194-6595-48EE-8548-F954E4722C2BQ39256704-F86A2F2B-4DA5-4F34-B9BF-80F3AD99C5A4
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2017-0683
@en
name
Christopher Blyth
@ast
Christopher Blyth
@en
Christopher Blyth
@es
Christopher Blyth
@nl
type
label
Christopher Blyth
@ast
Christopher Blyth
@en
Christopher Blyth
@es
Christopher Blyth
@nl
prefLabel
Christopher Blyth
@ast
Christopher Blyth
@en
Christopher Blyth
@es
Christopher Blyth
@nl
P106
P1153
55589360100
P21
P31
P496
0000-0003-2017-0683